Trial · NCT02485301
Results by group399
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 399
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects With Solicited Local Adverse Events | GSK3390107A Group | Any Pain | 356 | Participants | |
| Number of Subjects With Solicited Local Adverse Events | Placebo+GSK3390107A Group | Any Pain | 57 | Participants | |
| Number of Subjects With Solicited Local Adverse Events | GSK3390107A Group | Grade 3 Pain | 3 | Participants | |
| Number of Subjects With Solicited Local Adverse Events | Placebo+GSK3390107A Group | Grade 3 Pain | 0 | Participants | |
| Number of Subjects With Solicited Local Adverse Events | GSK3390107A Group | Any Redness | 2 | Participants | |
| Number of Subjects With Solicited Local Adverse Events | Placebo+GSK3390107A Group | Any Redness | 0 | Participants | |
| Number of Subjects With Solicited Local Adverse Events | GSK3390107A Group | Grade 3 Redness | 0 | Participants | |
| Number of Subjects With Solicited Local Adverse Events | Placebo+GSK3390107A Group | Grade 3 Redness | 0 | Participants | |
| Number of Subjects With Solicited Local Adverse Events | GSK3390107A Group | Any Swelling | 9 | Participants | |
| Number of Subjects With Solicited Local Adverse Events | Placebo+GSK3390107A Group | Any Swelling | 5 | Participants | |
| Number of Subjects With Solicited Local Adverse Events | GSK3390107A Group | Grade 3 Swelling | 0 | Participants | |
| Number of Subjects With Solicited Local Adverse Events | Placebo+GSK3390107A Group | Grade 3 Swelling | 0 | Participants | |
| Number of Subjects With Solicited General Adverse Events | GSK3390107A Group | Any Fatigue | 284 | Participants | |
| Number of Subjects With Solicited General Adverse Events | Placebo+GSK3390107A Group | Any Fatigue | 94 | Participants | |
| Number of Subjects With Solicited General Adverse Events | GSK3390107A Group | Grade 3 Fatigue | 11 | Participants | |
| Number of Subjects With Solicited General Adverse Events | Placebo+GSK3390107A Group | Grade 3 Fatigue | 3 | Participants | |
| Number of Subjects With Solicited General Adverse Events | GSK3390107A Group | Related Fatigue | 243 | Participants | |
| Number of Subjects With Solicited General Adverse Events | Placebo+GSK3390107A Group | Related Fatigue | 72 | Participants | |
| Number of Subjects With Solicited General Adverse Events | GSK3390107A Group | Any Fever | 106 | Participants | |
| Number of Subjects With Solicited General Adverse Events | Placebo+GSK3390107A Group | Any Fever | 24 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02485301/results